Glipizide
- Product NDC
- 50090-0502
- 11-digit product format
- 500900502
- Labeler code
- 50090
- Product ID
- 50090-0502_841961c3-76b4-4622-81dd-2cefbf29d3d2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA075795
- Marketing category
- ANDA
- Marketing start
- 2002-09-25
- Substance
- GLIPIZIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glipizide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GLIPIZIDE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | X7WDT95N5C |
| Rxcui | 310490 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 50090-0502-0 | 2023-02-07 | C162847 | 48780-1 | f386c649-e368-0266-e053-dadaa90a7c1a | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 50090-0502-1 | 2023-02-07 | C162847 | 48780-1 | f386c649-e368-0266-e053-dadaa90a7c1a | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 50090-0502-2 | 2023-02-07 | C162847 | 48780-1 | f386c649-e368-0266-e053-dadaa90a7c1a | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 50090-0502-3 | 2023-02-07 | C162847 | 48780-1 | f386c649-e368-0266-e053-dadaa90a7c1a | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 50090-0502-4 | 2023-02-07 | C162847 | 48780-1 | f386c649-e368-0266-e053-dadaa90a7c1a | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 50090-0502-0 | 2023-01-30 | C162847 | 48780-1 | f386c649-e368-0266-e053-dadaa90a7c1a | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 50090-0502-1 | 2023-01-30 | C162847 | 48780-1 | f386c649-e368-0266-e053-dadaa90a7c1a | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 50090-0502-2 | 2023-01-30 | C162847 | 48780-1 | f386c649-e368-0266-e053-dadaa90a7c1a | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 50090-0502-3 | 2023-01-30 | C162847 | 48780-1 | f386c649-e368-0266-e053-dadaa90a7c1a | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 50090-0502-4 | 2023-01-30 | C162847 | 48780-1 | f386c649-e368-0266-e053-dadaa90a7c1a | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-0502 | GLIPIZIDE TABLET [A-S MEDICATION SOLUTIONS] | 13 | Current NDC, Legacy NDC, 5 package rows | 20231110_16fb8bc7-1db1-477e-a201-b3b678b8a84c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-0502-0 | 50090050200 | 30 TABLET in 1 BOTTLE (50090-0502-0) | 30 tablet | 2016-06-29 | 0000-00-00 | No | No | Current |
| 50090-0502-1 | 50090050201 | 60 TABLET in 1 BOTTLE (50090-0502-1) | 60 tablet | 2016-06-29 | 0000-00-00 | No | No | Current |
| 50090-0502-2 | 50090050202 | 100 TABLET in 1 BOTTLE (50090-0502-2) | 100 tablet | 2016-06-29 | 0000-00-00 | No | No | Current |
| 50090-0502-3 | 50090050203 | 90 TABLET in 1 BOTTLE (50090-0502-3) | 90 tablet | 2016-06-29 | 0000-00-00 | No | No | Current |
| 50090-0502-4 | 50090050204 | 180 TABLET in 1 BOTTLE (50090-0502-4) | 180 tablet | 2016-06-29 | 0000-00-00 | No | No | Current |